JOURNAL REVIEWED: The Journal of Craniofacial Surgery
Latest Contribution
Eosinophilic complications during dupilumab therapy
Dupilumab is a humanised monoclonal antibody that targets type 2 inflammation by blocking IL-4 and IL-13 signalling. Reported adverse events from its use include injection site erythema, conjunctivitis, arthralgia and hypereosinophilia. The potential for more severe eosinophilic-related complications such as...
Canal cholesteatoma
This is a retrospective study of patients with external auditory canal cholesteatoma (EACC) managed at a single tertiary centre from 1 January 2010 to 1 January 2021. Ninety patients (100 ears) were included. Mean age at diagnosis was 56+23 years....
Budesonide nasal irrigation for chronic rhinosinusitis: is it effective and safe?
Budesonide respules used in nasal irrigations as part of chronic rhinosinusitis management are usually at a dose of 0.25 mg to 2 mg, which is substantially higher compared to budesonide nasal spray, typically ranging from 64 to 256 micrograms. Hence,...
